The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Skin toxicity associated with outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) with EGFR mutations in the EURTAC study.
Cristina Buges
No relevant relationships to disclose
Alex Martinez Marti
No relevant relationships to disclose
Rafael Rosell
No relevant relationships to disclose
Alain Vergnenegre
No relevant relationships to disclose
Filippo De Marinis
No relevant relationships to disclose
Bartomeu Massuti
No relevant relationships to disclose
Javier De Castro
No relevant relationships to disclose
Radj Gervais
No relevant relationships to disclose
Enric Carcereny Costa
No relevant relationships to disclose
Teresa Moran
No relevant relationships to disclose
Mariacarmela Santarpia
No relevant relationships to disclose
Enriqueta Felip
No relevant relationships to disclose
Margarita Majem
No relevant relationships to disclose
Rut Porta
No relevant relationships to disclose
Ramon Palmero
No relevant relationships to disclose
Ana Drozdowskyj
No relevant relationships to disclose
Cordula Heidecke
No relevant relationships to disclose
Amaya Gasco
No relevant relationships to disclose
Miquel Taron
No relevant relationships to disclose
Luis G. Paz-Ares
No relevant relationships to disclose